How bacteria corrupt the host vesicular trafficking:Role of SNARE-like Proteins

细菌如何破坏宿主囊泡运输:圈套样蛋白的作用

基本信息

  • 批准号:
    8288789
  • 负责人:
  • 金额:
    $ 34.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2014-08-18
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infectious diseases of bacterial origin have made a dramatic comeback, highlighting the urgency to develop new therapeutic tools. However, a better understanding of host-pathogen interaction at the cellular and molecular level is needed to define new targets. Our long-term goal is to develop such new therapeutic tools. Different pathogens use a variety of molecular machineries to penetrate host cells and manipulate intracellular vesicular trafficking. For instance, viruses employ glycoproteins, which are structurally and functionally similar to the SNARE proteins that mediate eukaryotic membrane fusion and vesicular trafficking. Large scale sequencing of bacterial genomes has revealed that many bacteria also express membrane proteins with homology to the eukaryotic SNARE fusion machinery components. These SNARE-like proteins might share similar functions and could be used by microorganisms to either block or promote membrane fusion. This project will test the hypothesis that bacterial SNARE-like proteins interact with the eukaryotic SNAREs to manipulate membrane fusion to their advantage. First, we will explore the interaction between bacterial SNARE-like proteins and mammalian SNAREs, using two Chlamydia and two Legionella SNARE-like proteins as our models. Next, we will assess the effect of bacterial SNARE-like proteins on mammalian SNARE- mediated membrane fusion. Finally, we will identify and characterize the functions of the bacterial SNARE-like protein bioactive domains. The presence of SNARE-like proteins in different pathogenic organisms indicates that the SNARE motif may have been selected during evolution because it is an efficient structural motif for manipulating eukaryotic membrane fusion and thus contribute to pathogen survival. Such a recurrence would allow us to develop a common strategy for targeting a wide array of bacterial SNARE-like proteins. Designing new bacterial therapeutics capable of corrupting the bacterial SNARE-like domains should revert the blockage of fusion and allow bacteria clearance by the phagosomes. PUBLIC HEALTH RELEVANCE: This research project proposes to determine whether intracellular bacteria utilize SNARE-like proteins to manipulate host vesicular trafficking pathways. Results will contribute to a better understanding of how parasite-containing vacuoles bypass lysosomal degradation and will shed light on the mechanism of parasitic intracellular survival. Additionally, the proposed studies have practical applications for the development of new therapeutic approaches to induce the clearance of intracellular bacteria by the host cell.
描述(申请人提供):细菌源的传染病已经戏剧性地卷土重来,突显了开发新的治疗工具的紧迫性。然而,需要在细胞和分子水平上更好地了解宿主与病原体的相互作用,以定义新的靶点。我们的长期目标是开发这种新的治疗工具。不同的病原体使用不同的分子机制来穿透宿主细胞并操纵细胞内的囊泡运输。例如,病毒使用的糖蛋白在结构和功能上与介导真核膜融合和囊泡运输的SNARE蛋白相似。对细菌基因组的大规模测序表明,许多细菌也表达与真核细胞中的SNARE融合机制组件同源的膜蛋白。这些类似陷阱的蛋白质可能具有类似的功能,微生物可以利用它们来阻止或促进膜融合。这个项目将测试这样的假设,即细菌陷阱样蛋白与真核细胞陷阱相互作用,操纵膜融合,使之对它们有利。首先,我们将使用两个衣原体和两个军团菌陷阱样蛋白作为我们的模型来探索细菌陷阱样蛋白和哺乳动物陷阱之间的相互作用。接下来,我们将评估细菌陷阱样蛋白在哺乳动物陷阱介导的膜融合中的作用。最后,我们将鉴定和鉴定细菌陷阱样蛋白生物活性结构域的功能。不同病原生物中SNARE样蛋白的存在表明,SNARE基序可能是在进化过程中被选择的,因为它是操纵真核膜融合的有效结构基序,从而有助于病原菌的生存。这样的反复将使我们能够开发出一种共同的策略,针对广泛的细菌陷阱样蛋白。设计能够破坏细菌陷阱状结构域的新细菌疗法应该会逆转融合的阻碍,并允许吞噬小体清除细菌。公共卫生相关性:该研究项目建议确定细胞内细菌是否利用陷阱样蛋白来操纵宿主囊泡运输途径。这些结果将有助于更好地理解含有寄生虫的空泡如何绕过溶酶体的降解,并将有助于揭示寄生虫细胞内生存的机制。此外,建议的研究在开发新的治疗方法以诱导宿主细胞清除细胞内细菌方面具有实际应用价值。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.
大肠杆菌暴露会抑制肥大细胞中胞吐 SNARE 介导的膜融合。
  • DOI:
    10.1111/tra.12159
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wesolowski,Jordan;Paumet,Fabienne
  • 通讯作者:
    Paumet,Fabienne
SNARE motif: a common motif used by pathogens to manipulate membrane fusion.
SNARE 基序:病原体用来操纵膜融合的常见基序。
  • DOI:
    10.4161/viru.1.4.12195
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Wesolowski,Jordan;Paumet,Fabienne
  • 通讯作者:
    Paumet,Fabienne
The impact of bacterial infection on mast cell degranulation.
细菌感染对肥大细胞脱粒的影响。
  • DOI:
    10.1007/s12026-011-8250-x
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Wesolowski,Jordan;Paumet,Fabienne
  • 通讯作者:
    Paumet,Fabienne
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FABIENNE Michelle PAUMET其他文献

FABIENNE Michelle PAUMET的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FABIENNE Michelle PAUMET', 18)}}的其他基金

Control of lipid droplet homeostasis by Chlamydia
衣原体对脂滴稳态的控制
  • 批准号:
    10300188
  • 财政年份:
    2021
  • 资助金额:
    $ 34.07万
  • 项目类别:
Control of lipid droplet homeostasis by Chlamydia
衣原体对脂滴稳态的控制
  • 批准号:
    10439872
  • 财政年份:
    2021
  • 资助金额:
    $ 34.07万
  • 项目类别:
How chlamydia generates cytoskeletal scaffolds and their role during infection
衣原体如何产生细胞骨架支架及其在感染过程中的作用
  • 批准号:
    10318117
  • 财政年份:
    2019
  • 资助金额:
    $ 34.07万
  • 项目类别:
How chlamydia generates cytoskeletal scaffolds and their role during infection
衣原体如何产生细胞骨架支架及其在感染过程中的作用
  • 批准号:
    10539241
  • 财政年份:
    2019
  • 资助金额:
    $ 34.07万
  • 项目类别:
How chlamydia generates cytoskeletal scaffolds and their role during infection
衣原体如何产生细胞骨架支架及其在感染过程中的作用
  • 批准号:
    10077785
  • 财政年份:
    2019
  • 资助金额:
    $ 34.07万
  • 项目类别:
Regulation of membrane fusion in macrophage phagocytosis
巨噬细胞吞噬作用中膜融合的调节
  • 批准号:
    8683383
  • 财政年份:
    2014
  • 资助金额:
    $ 34.07万
  • 项目类别:
Regulation of membrane fusion in macrophage phagocytosis
巨噬细胞吞噬作用中膜融合的调节
  • 批准号:
    8885649
  • 财政年份:
    2014
  • 资助金额:
    $ 34.07万
  • 项目类别:
How bacteria corrupt the host vesicular trafficking:Role of SNARE-like Proteins
细菌如何破坏宿主囊泡运输:圈套样蛋白的作用
  • 批准号:
    7872803
  • 财政年份:
    2009
  • 资助金额:
    $ 34.07万
  • 项目类别:
How bacteria corrupt the host vesicular trafficking:Role of SNARE-like Proteins
细菌如何破坏宿主囊泡运输:圈套样蛋白的作用
  • 批准号:
    7727695
  • 财政年份:
    2009
  • 资助金额:
    $ 34.07万
  • 项目类别:
How bacteria corrupt the host vesicular trafficking:Role of SNARE-like Proteins
细菌如何破坏宿主囊泡运输:圈套样蛋白的作用
  • 批准号:
    8107645
  • 财政年份:
    2009
  • 资助金额:
    $ 34.07万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 34.07万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 34.07万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 34.07万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 34.07万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 34.07万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了